New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a ...

The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Repeated insulin shots at the same site can seed amyloid; consider this diagnosis if absorption seems erratic or glucose control worsens with a persistent lump.

After living with oesophageal adenocarcinoma for nearly five years, my dad had wound up in the emergency room on Dec. 1 with ...

A groundbreaking Swedish study, co-authored by a University of Brescia researcher, unveils a potential game-changer: a ...

BrainSpace, a medtech focused on neurological injuries and illnesses, received 501 (k) clearance from the FDA for its brain ...

BrainSpace announced that the FDA granted 510(k) clearance for its Intellidrop automated brain fluid management system.

Ceribell received breakthrough device designation for its LVO stroke detection monitor, and Naox Technologies secured 510(k) clearance for its in-ear EEG device.

BrainSpace, a medical technology company building automated solutions for neuro injury, illness and degeneration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...